BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190523
DTSTAMP:20260515T001923
CREATED:20181214T110222Z
LAST-MODIFIED:20181214T110356Z
UID:18840-1558396800-1558569599@www.pharmajournalist.com
SUMMARY:3rd Annual Digi-Tech Pharma 2019
DESCRIPTION:Our upcoming conference 3rd Annual Digi-Tech Pharma 2019 (Pharmaceutical technology conference 2019)\, will provide a platform to all its participants an opportunity to interact\, share and discuss the digitalization of Pharma industry. The conference will allow its participants to discuss the various challenges faced\, new strategies\, case studies and use of innovative ideas in the field of Digital Pharma IT. Also\, to stay updated on the latest trends in digital\, social media and mobile strategies required to overcome the obstructions in the transformation. This Digi-Tech Pharma 2019 is a unique platform in the pharmaceutical conferences which will allow IT leaders to share their technologies and strategies to help the pharma industries avail new opportunities to encourage partnerships and collaborations.
URL:https://www.pharmajournalist.com/event/3rd-annual-digi-tech-pharma-2019/
LOCATION:London\, United Kingdom
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190523
DTSTAMP:20260515T001923
CREATED:20190108T102702Z
LAST-MODIFIED:20190108T102702Z
UID:18969-1558310400-1558569599@www.pharmajournalist.com
SUMMARY:Plant Genomics and Gene Editing Congress: Europe
DESCRIPTION:Global Engage is pleased to announce the 7th Plant Genomics & Gene Editing Congress: Europe\, taking place 21st-22nd May 2019\, in Rotterdam\, The Netherlands. This event is part of our widely-regarded Plant Genomics Series which includes an Asian and US meeting each year. \nAttracting over 300 experts working in all areas of plant science\, this event will examine the latest in gene editing methods for plant genomics research. CRISPR/Cas9 case studies and the very best strategies for plant genome engineering will be presented by industry leaders\, experts\, and pioneering academics at the forefront of plant research. Developments in gene editing\, NGS\, and omic technologies will all be explored for crop trait development\, disease resistance\, epigenetics\, plant breeding\, and more. Tracks dedicated to plant & soil microbiomes\, and the importance of plant phenotyping in the context of bioinformatics challenges\, will encourage a holistic approach to plant research; the former will focus on identifying microbes to enhance crop productivity & disease resistance\, while the latter will showcase the best tools for overcoming bioinformatics bottlenecks\, applicable to plant research across the board. We will also be looking to examine the impact of the ECJ’s latest interpretation of GMO regulations\, and what this means for the future of gene editing research\, addressing issues such as how to navigate the new legislation\, and considering what alternative strategies & technologies there might be for progressing plant genomics.
URL:https://www.pharmajournalist.com/event/plant-genomics-and-gene-editing-congress-europe/
LOCATION:Rotterdam\, The Netherlands Postilion Convention Centre WTC Rotterdam\, Rotterdam\, Netherlands
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190523
DTSTAMP:20260515T001923
CREATED:20190108T102413Z
LAST-MODIFIED:20190108T102413Z
UID:18964-1558310400-1558569599@www.pharmajournalist.com
SUMMARY:Microbiome & Probiotics Series: Europe
DESCRIPTION:Part of the leading global microbiome and probiotics conference series\, the 2019 European event will bring together more than 400 industry\, academic\, and investment leaders to discuss the must cutting-edge microbiome and probiotics research\, challenges and opportunities in moving research towards commercialisation\, and potential partnerships and collaborations. \nFor the first time\, this event will be three days. As an attendee\, you will get more in-depth content on the key challenges and topics facing researchers and product developers\, and more time to establish partnerships. Hear from top scientists in the field\, meet willing investors and collaborators\, and learn about exciting new companies in the microbiome space. With ample networking time and interactive sessions like the roundtable discussions\, there will be many opportunities to broaden your connections.
URL:https://www.pharmajournalist.com/event/microbiome-probiotics-series-europe/
LOCATION:Rotterdam\, The Netherlands Postilion Convention Centre WTC Rotterdam\, Rotterdam\, Netherlands
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190522
DTSTAMP:20260515T001923
CREATED:20190108T101939Z
LAST-MODIFIED:20190108T103213Z
UID:18959-1558310400-1558483199@www.pharmajournalist.com
SUMMARY:Global Bioprocessing\, Bioanalytics and ATMP Manufacturing Congress
DESCRIPTION:This comprehensive two-day congress features 30 presentations given across four tracks. It will provide experts with an exceptional environment in which to examine the key developments occurring today. Topics covered includethe automation of vaccine formulations\, purification technologies\, T-cell manufacturing and glycoanalytic technologies.
URL:https://www.pharmajournalist.com/event/global-bioprocessing-bioanalytics-and-atmp-manufacturing-congress/
LOCATION:Dublin\, Ireland\, Hotel Riu Plaza The Gresham Dublin\, Dublin\, Ireland
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190515
DTEND;VALUE=DATE:20190517
DTSTAMP:20260515T001923
CREATED:20190114T083448Z
LAST-MODIFIED:20190123T091623Z
UID:19074-1557878400-1558051199@www.pharmajournalist.com
SUMMARY:SMi Presents the 2nd Annual Conference: Injectable Drug Delivery 2019
DESCRIPTION:The SMi Group is pleased to announce the second annual Injectable Drug Delivery conference which will be held in London on the 15th and 16th May 2019. \nThe global injectable drug delivery market is expected to grow from $400 billion to $1200 billion by 2046 with a CAGR of 12.8%. \n \nInjectable drug delivery is a method of drug administration into the body with a needle via various routes including intramuscular and intravenous. These are examples of conventional drug delivery. Recently\, there has been a focus on novel drug delivery\, including needle-free injectors\, and transdermal patches. Long acting injectables (LAI) are developing fast as a push towards patient centric devices drives the industry. Habitually\, injectables were used for delivery of hormones\, vaccines and insulin but as technology advances the application is continuing to expand. Now there is an emphasis on finding solutions to chronic conditions and the biological drugs required involve formulation development challenges for proteins\, including high viscosity and high volume. Self-administrative\, connected\, and ergonomic devices are the new drive. Self-injectable devices include pen injectors for diabetic patients. The wealth of expansion available in the field of connected devices is huge. The regulatory landscape is challenging as it evolves rapidly with the market demand for new devices. \nThe benefits of attending: \nDeveloping on last year’s success\, this event assembles an international audience to include regulatory\, device design\, packaging and formulation professionals.  The devices need to be designed for the new generation of drugs and they need to provide safety with a strong patient focus. This event is will help inspire you to help drive this industry forward and learn about the predicted market trends\, critical digital and chemical developments and the push for patient compliance in a changing regulatory landscape. \nThis conference offers a chance to learn about innovative injectable drug delivery systems with industrial insights on the following: \n– Life cycle management for developing devices that are both user friendly and revenue effective\n– Device design considerations\n– Long acting injectables and bringing these therapeutics to market with case studies\n– Connected devices\, GDPR and cyber security programs\n– Developments in primary packaging\n– Growth in transdermal delivery and subcutaneous infusion devices\n– Digital health partnerships\n– Large volume patch pump innovation examples \nWho should attend \nExecutives\, Directors\, VPs\, Heads\, Principals\, Managers\, Scientists\, Researchers of: \n\nAutoinjectors\nWearables\nDevice Engineering\nHuman Factors\nCMC\nInjectables\nSterile Manufacturing\nPackaging\nRegulatory Affairs\n\nFeatured Speakers: \n\nBjorg K. Hunter\, Device Engineering Manager\, GSK\nMiranda Newbery\, Human Factors Consultant\, Inspired Usability\nBlake Green\, Regulatory Affairs Senior Manager\, Devices\, Amgen\nQuentin Le Masne\, Head of Engineering team – Electro-Medical / Drug Delivery Devices\, Merck\nVasco Filipe\, Formulation and Drug Process Development Section Head for Biologics\, Sanofi\nStephen Paboojian\, Senior Project Leader I for Device Development\, Novartis\nTom Lawrie-Fussey\, Digital Services Specialist\, Cambridge Design Partnership\nTerry Reed\, Director of Business development\, AstraZeneca\nJoel Richard\, Head of Technical and Pharmaceutical Operations\, MedinCell\n\n*Plus\, pre-conference workshops – 14th May 2019 \nEARLY-BIRD RATES: \n\nBOOK BY 31st JANUARY AND SAVE £400\nBOOK BY 28th FEBRUARY AND SAVE £200\nBOOK BY 29th MARCH AND SAVE £100\n\nLinkedIn: @SMi Pharma \nTwitter: @SMiPharm #SMi \nTo learn more about this event\, and to register online\, visit www.injectable-drug-delivery.com/pharmajwl
URL:https://www.pharmajournalist.com/event/injectable-drug-delivery-2019/
LOCATION:Copthorne Tara Hotel London Kensington\, Copthorne Tara Hotel London Kensington\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190508
DTEND;VALUE=DATE:20190510
DTSTAMP:20260515T001923
CREATED:20181214T105212Z
LAST-MODIFIED:20181214T105212Z
UID:18835-1557273600-1557446399@www.pharmajournalist.com
SUMMARY:GLOBAL CLINICAL TRIALS CONNECT 2018 (Collaboration\, Innovation And Enhancing Quality In Clinical Trials )
DESCRIPTION:The  Global Clinical Trials Connect 2019 conference focuses on introducing pioneer technology\, developing better patient engagement and collaborating strategies in clinical trials. With the right commitment and attention to detail\, contract research organizations (CROs) and pharmaceutical companies can drive collaboration with greater efficiency. This conference will bring together the industry experts and leaders across pharmaceutical\, biotechnological and CRO’s for brainstorming on Case studies on innovation\, collaboration and existing clinical data to headway the Clinical Trials process. Ethical considerations are given in this context and for this RBM are beginning to extend its concepts in Quality Risk Management; clinical trial predictive models are accumulated by enterprises\, methodologies in trial design and many more.
URL:https://www.pharmajournalist.com/event/global-clinical-trials-connect-2018-collaboration-innovation-and-enhancing-quality-in-clinical-trials/
LOCATION:London\, United Kingdom
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190507
DTEND;VALUE=DATE:20190510
DTSTAMP:20260515T001923
CREATED:20190313T080024Z
LAST-MODIFIED:20190313T080024Z
UID:19944-1557187200-1557446399@www.pharmajournalist.com
SUMMARY:Extractables & Leachables USA 2019
DESCRIPTION:Extractables & Leachables USA brings together leading E&L experts and decision makers from across the supply chain to get the latest updates on regulations\, best practices\, safety compliance\, biocompatibility\, advancements in the sector\, working group updates\, and much more. Taking place May 7-9\, 2019\, at the Westin Arlington Gateway in Arlington\, Virginia – this event offers the unique opportunity to make new connections\, network with peers\, share new information\, and discuss the key topics\, trends\, and new industry developments that are affecting the E&L marketplace. Use code PHARM19 to SAVE 15% off the current ticket price!
URL:https://www.pharmajournalist.com/event/extractables-leachables-usa-2019/
LOCATION:Westin Arlington Gateway – 801 N Glebe Rd\, Arlington\, VA 22203\, United States
ORGANIZER;CN="Smithers Rapra":MAILTO:aszymanski@smithers.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190506
DTEND;VALUE=DATE:20190509
DTSTAMP:20260515T001923
CREATED:20190201T151752Z
LAST-MODIFIED:20190201T151752Z
UID:19366-1557100800-1557359999@www.pharmajournalist.com
SUMMARY:2nd Annual CKD3 Summit
DESCRIPTION:Chronic Kidney Disease Drug Development (CKD3) is a uniquely focused conference that unites key opinion leaders in this field to identify and discuss the critical factors determining the success of current CKD pipelines and significantly impact the standard of care for this huge unmet medical need. \n \nBringing together leading experts from innovative biotechs\, large pharma\, academia and key service provider companies\, CKD3 will present comprehensive insight into the cutting edge progress of CKD drug development research. \nTo learn more and to register online\, visit https://ter.li/10so2k
URL:https://www.pharmajournalist.com/event/2nd-annual-ckd3-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart St\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190430
DTEND;VALUE=DATE:20190502
DTSTAMP:20260515T001923
CREATED:20190110T103553Z
LAST-MODIFIED:20190110T110108Z
UID:18984-1556582400-1556755199@www.pharmajournalist.com
SUMMARY:Clinical Operations in Oncology Trials to the West Coast 2019
DESCRIPTION:Arena International is excited to announce the return of the 6th Annual Clinical Operations in Oncology Trials to the West Coast on April 30th – May 1st 2019. \nAs one of the only oncology operationally focused events in the West Coast\, this meeting will aim to provide strategies to allow for operationally meaningful and targeted oncology trials to engage West Coast physicians and patients. \nThe event will be led by a myriad of industry specialists from the West Coast who will deliver solution and strategy through a variety of interactive formats: panel discussion\, spotlight Q&As\, roundtables and more! This conference will also provide a platform for industry professionals to network with some of the most innovative vendors in the market. \nWhile maintaining the primary focus of its previous years\, our 2019 event will look at how to prepare for the ever-changing dynamic of the oncology industry\, and provide insight into the latest technological and therapeutic solutions. \nWe hope to see you in April\, make sure to register your place today!
URL:https://www.pharmajournalist.com/event/clinical-operations-in-oncology-trials-to-the-west-coast-2019/
LOCATION:Burlingame\, California
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190423
DTEND;VALUE=DATE:20190426
DTSTAMP:20260515T001923
CREATED:20190220T073616Z
LAST-MODIFIED:20190220T073737Z
UID:19651-1555977600-1556236799@www.pharmajournalist.com
SUMMARY:European NeoAg Summit
DESCRIPTION:With an exclusive case-study led agenda\, the European NeoAg Summit will paint a fuller picture of neoantigen presentation and T-cell interaction. Hear updates on clinical trials results to help you further determine neoantigen immunogenicity. \nIn addition\, gain practical insights on personalised cancer vaccine and cell therapy global clinical development\, as well as regulatory guidance. \nJoin the gathering of over 100 personalised cancer immunotherapy pioneers from pharma and biotech including Ziopharm\, Genocea\, Vaccibody and more to advance neoantigen based cancer vaccines and cell therapies. \nFor more information\, visit www.neoantigen-europe.com 
URL:https://www.pharmajournalist.com/event/european-neoag-summit/
LOCATION:Amsterdam Marriot Hotel  Stadhouderskade 12\, 1054 ES  Amsterdam\, Netherlands
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190419
DTSTAMP:20260515T001923
CREATED:20190220T073216Z
LAST-MODIFIED:20190220T073349Z
UID:19646-1555372800-1555631999@www.pharmajournalist.com
SUMMARY:Neuroimmunology Drug Development Summit (NIDD)
DESCRIPTION:Built with thought-leaders at Sanofi\, Eisai\, AbbVie and Denali\, the inaugural NIDD Summit will share the field’s cutting-edge scientific advances enabling you to translate your neuroimmunology research into a clinically effective therapeutic for neurological diseases. \n\nWith an emphasis on neurodegeneration\, chronic neuroinflammatory mechanisms will be explored whilst addressing your drug development challenges: \n\nDiscover robust biomarkers of neuroinflammation to enable successful translation and patient stratification\nNavigate preclinical model limitations to better predict clinical efficacy\nExplore the identification and validation of neuroimmunological targets and assess novel therapeutic approaches\n\nDon’t miss this opportunity to learn from 20+ industry expert speakers to effectively target neuroimmunological mechanisms and rapidly progress your research to the clinic. \nFor more information\, visit www.neuroimmunology-drugdevelopment.com
URL:https://www.pharmajournalist.com/event/neuroimmunology-drug-development-summit-nidd/
LOCATION:Hyatt Regency Boston  One Avenue de Lafayette\, Boston  Massachusetts\, United States\, 02111
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190418
DTSTAMP:20260515T001923
CREATED:20190108T073610Z
LAST-MODIFIED:20190108T073610Z
UID:18942-1555372800-1555545599@www.pharmajournalist.com
SUMMARY:CAR-T Congress USA
DESCRIPTION:CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. With the recent approvals of Yescarta and Kymriah and the $11 billion acquisition of Kite\, the race is on to lead the commercialization of safe\, efficacious and accessible CAR-T therapy. \n \nThe fourth annual CAR-T congress USA provides a platform for emerging novel data in small scale clinical trials ran by the leading academic institutions\, including MD Anderson and the University of Pennsylvania. \nHear first-hand\, the emerging areas of research from new companies into single patient experiences\, as well as context around patient relapses and methods of toxicity management. \nJoin thought leaders from biotechs\, pharmaceutical companies and academia to address the challenges of CAR-T therapy including toxicity\, scalability and efficacy in both liquid and solid tumours. \nDiscover how CAR-T compares to standard treatments and advances in genome editing tools\, the new methods in allogeneic and autologous process development and the pre-clinical concepts that will pave the way for novel antigen discovery. \nBe part of the movement that engineers a strategy to reprogram the cancer treatments we know today. \nBook before January 25 to save up to $800.  To learn more about this event and to book online visit: www.car-tcongress.com/register
URL:https://www.pharmajournalist.com/event/car-t-congress-usa/
LOCATION:Hyatt Regency Boston Harbor\, 101 Harborside Drive\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190418
DTSTAMP:20260515T001923
CREATED:20181005T132158Z
LAST-MODIFIED:20181005T132334Z
UID:17940-1555372800-1555545599@www.pharmajournalist.com
SUMMARY:17th annual eyeforpharma Philadelphia Conference
DESCRIPTION:Where pharma’s performance is built by patient value \nThe world’s greatest gathering of pharma’s value-designers \nEvery important industry player in one room\, evolving our antiquated model by embracing value-based care. That’s the vision for eyeforpharma Philadelphia\, the flagship event where pharma\, patients and payers co-design for outcomes. \nThere are dozens of events on digital\, on patient centricity\, on data\, on access\, on medical\, on commercial. Only one event brings all the key designers together so that we can address unmet need\, create solutions that cover the spectrum\, and end the age-old problems of misalignment. \nJoin us for pharma’s most influential meeting – as we write the blueprint for healthcare’s future. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2O8ldd5
URL:https://www.pharmajournalist.com/event/17th-annual-eyeforpharma-philadelphia-conference/
LOCATION:Pennsylvania Convention Center\, 1101 Arch St\, Philadelphia\, PA\, 19107\, United States
ORGANIZER;CN="eyeforpharma":MAILTO:jbramwell@eyeforpharma.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190401
DTEND;VALUE=DATE:20190403
DTSTAMP:20260515T001923
CREATED:20181121T114612Z
LAST-MODIFIED:20181130T122336Z
UID:18473-1554076800-1554249599@www.pharmajournalist.com
SUMMARY:Adaptive Designs in Clinical Trials 2019
DESCRIPTION:SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials conference and exhibition will return to London from the 1st – 2nd April 2019. With the growing popularity in use and acceptance of adaptive designs in clinical trials – demonstrated most recently with the new FDA draft guidance on adaptive designs – there is a pressing need for a forum which explores this increasingly normalized medical methodology. \n \nHosting in depth presentations from regulatory agencies\, researchers and biostatisticians\, the meeting will cover how personalized medicine\, platform trials\, response-adaptive randomization\, signature designs\, estimand framework\, Bayesian methods and digital innovation are revolutionizing the drug development process both in Europe and North America. \nTo learn more and to register online\, visit www.adaptivedesigns.co.uk/pharmajwl
URL:https://www.pharmajournalist.com/event/adaptive-designs-in-clinical-trials-2019/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190327
DTEND;VALUE=DATE:20190328
DTSTAMP:20260515T001923
CREATED:20190308T084926Z
LAST-MODIFIED:20190308T084926Z
UID:19867-1553644800-1553731199@www.pharmajournalist.com
SUMMARY:The Pharma Gorilla
DESCRIPTION:The Pharma Gorilla will be held on March 27\, 2019 in Hilton Mumbai International Airport\, Mumbai\, India. It provides the opportunity to learn\, engage and network for the pharmaceutical and healthcare fraternity. This conference is designed to address practical issues and topics for Corporates\, scientists\, professors\, business representatives\, and healthcare providers to discuss the latest innovations\, trends and concerns\, practical challenges and solutions in Pharma. \nThe objective of this conference to share expertise addressing the current advancements involved in the Pharmaceutical industry. The knowledgeable intriguing sessions will create an ideal platform to get acquainted with the latest trends\, advancements\, and future of the pharmaceutical sciences. It is a wonderful opportunity for all the participants as it provides a networking opportunity to collaborate with the world class Pharmaceutical and healthcare industry. \nThe Pharma Gorilla provides a perfect platform for conducting presentations\, keynote sessions\, sharing the knowledge\, one on one meeting with your potential audience and getting acquainted with the latest developments in the pharmaceutical and healthcare industry to stand out of the competition.
URL:https://www.pharmajournalist.com/event/the-pharma-gorilla/
LOCATION:Hilton Mumbai International Airport\, Mumbai\, India
ORGANIZER;CN="The Conference Gorilla":MAILTO:contact@theconferencegorilla.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190326
DTEND;VALUE=DATE:20190328
DTSTAMP:20260515T001923
CREATED:20190110T101919Z
LAST-MODIFIED:20190110T101919Z
UID:18980-1553558400-1553731199@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply New England 2019
DESCRIPTION:This year’s Clinical Trial Supply New England celebrates its 8th year and will be hosted on the 26th – 27th of March. \nIn 2019 we have worked hard to prepare a leading industry agenda which makes this event a must attend in the industries calendar. We have built on last year’s success conference and are returning with full force to Boston with the aim of supporting trial sponsors and solution providers across New England to ensure trials are delivered on time\, partnerships are improved and supply chain uncertainties are resolved. \nWe will once again be meeting in to discuss\, deliberate and debate the latest operational and technological challenges with regards to clinical trial supplies. Over the course of two days you can expect to catch-up with old colleagues and make new lasting business connections to help drive success in your trials. As Arena’s dedicated Clinical Trial Supply conference for the New England area\, this event caters to local needs while offering the change to meet international sponsors and solution providers. \nAt each Clinical Trial Supply conference we create a welcoming networking environment and an educational program packed with the latest case studies\, techniques and providers to set your trial apart. This year is no different as we have a vast array of fascinating case-studies\, thought leading presentations and engaging panels. \nThis year we will be looking at those issues which are affecting companies in the Boston-Cambridge hub\, such as but no limited to: ways to move beyond the theory; harnessing the power of technology to design a functioning Direct to Patient (DtP) supply chain\, discovering how to incorporate gene therapies within your supply chain and blockchain: a discussion of practical applications for clinical supply chain and life-sciences. \nWith such a packed program you can’t afford to miss out. We look forward to meeting you in Boston so make sure to book your place today!
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-new-england-2019/
LOCATION:Boston\, Massachusetts
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190326
DTEND;VALUE=DATE:20190329
DTSTAMP:20260515T001923
CREATED:20181126T151827Z
LAST-MODIFIED:20181126T151827Z
UID:18552-1553558400-1553817599@www.pharmajournalist.com
SUMMARY:Gene Therapy for Rare Disorders
DESCRIPTION:Gene Therapy for Rare Disorders is a uniquely focused conference that unites the leaders in the field to identify and discuss the critical factors that will influence genetic treatments most significantly in the near future. \n \nIncorporating insights from 50+ industry-leading speakers\, the meeting delves into the key regulatory\, reimbursement\, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies. \nBringing together leading experts from innovative biotechs\, large pharma\, academia and key service provider companies\, Gene Therapy for Rare Disorders will present a comprehensive insight into the cutting edge progress of gene therapies combatting rare disease. \nJoin 350+ of your colleagues to accelerate the progress of the next generation of gene therapies that show improved efficacy\, enhanced safety and commercial viability. \nTo learn more and to register online\, visit https://bit.ly/2ByuEe2
URL:https://www.pharmajournalist.com/event/gene-therapy-for-rare-disorders/
LOCATION:The Westin Boston Waterfront\, 425 Summer St\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190322
DTSTAMP:20260515T001923
CREATED:20190219T121841Z
LAST-MODIFIED:20190219T121841Z
UID:19638-1552953600-1553212799@www.pharmajournalist.com
SUMMARY:Innate Killer Summit 2019
DESCRIPTION:Accelerate to Market Genetically Engineered\, Off-the-Shelf and Cost Effective NK Cell Immunotherapies for Solid Tumor Indications \n The Innate Killer Summit 2019 discusses safer\, more cost-effective and potentially more efficacious NK cell immunotherapy as the next generation of frontline cancer therapy. \n \nIt will help you to optimize your manufacturing and process development strategies to further reduce the cost of off-the-shelf NK cell therapies. Discuss the most up to date clinical data on genetically engineered NK cells from CARs to bispecific engagers and ensure persistence and durability. \nBringing together over 100 of the field’s leading minds to share experience and knowledge on the optimal NK cell source and improve the efficacy of NK cell therapies through enhanced targeting methods. Join us at the 4th Annual Innate Killer Summit to bring to patients the next generation of cell immunotherapies that are safer and cheaper.
URL:https://www.pharmajournalist.com/event/innate-killer-summit-2019/
LOCATION:Hilton San Diego Gaslamp Quarter\, 401 K St\, San Diego\, CA 92101
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190321
DTSTAMP:20260515T001923
CREATED:20181214T104719Z
LAST-MODIFIED:20181214T104719Z
UID:18830-1552953600-1553126399@www.pharmajournalist.com
SUMMARY:Pharma Security World 2019 - Anti-Counterfeiting\, Drug Serialization and Supply-Chain Security Conference
DESCRIPTION:The Counterfeit medicines are turning into a serious concern around the world\, and have progressively been showing up through the real pharmaceutical supply chain\, including community and online drug stores. What’s more\, pharmaceutical companies and regulators are creating ways to stop them. No nations stay untouched by this issue\, what was once viewed as an issue endured by developing nations has now turned into an issue to developing nations including US and Europe. We require both countrywide and industry-level participation\, and in addition public and private sector coordinated effort\, to identify and definitively battle counterfeiters. To protect your brand and build a genuine future\, Corvus Global Events invites you to Pharma Security World 2019 – Supply-Chain\, Drug Serialization and Anti-Counterfeiting Conference\, which will have Pharma industry experts sharing various challenges faced\, new strategies\, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations.
URL:https://www.pharmajournalist.com/event/pharma-security-world-2019-anti-counterfeiting-drug-serialization-and-supply-chain-security-conference/
LOCATION:London\, United Kingdom
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190322
DTSTAMP:20260515T001923
CREATED:20181109T151157Z
LAST-MODIFIED:20181126T130220Z
UID:18365-1552953600-1553212799@www.pharmajournalist.com
SUMMARY:ePharma IMPACT
DESCRIPTION:ePharma IMPACT brings together the most influential players across the digital marketing spectrum to reveal truly innovative\, next generation omni-channel strategies. \nThe 3-day event is designed to help you take command of the most influential strategies on the horizon so you can confidently determine where your next digital marketing dollar should be spent for maximum impact. \nHow do we deliver on that promise? By offering a diversified experience like you won’t find anywhere else. One that translates directly into stronger patient and HCP relationships\, and greater influence over impactful marketing strategy. \nThe 12th annual conference is THE event leading pharma companies rely on to stay ahead of digital disruption and translate digital marketing strategies into bottom line impact.
URL:https://www.pharmajournalist.com/event/epharma-impact/
LOCATION:NY Hilton 1335 Ave of the Americas New York\, NY 10017\, NY\, United States
ORGANIZER;CN="Knect365":MAILTO:register@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190319
DTEND;VALUE=DATE:20190321
DTSTAMP:20260515T001923
CREATED:20171108T010017Z
LAST-MODIFIED:20181122T123741Z
UID:3856-1552953600-1553126399@www.pharmajournalist.com
SUMMARY:ProcureCon Pharma 2019
DESCRIPTION:Taking place on 19th-20th March 2019 in Frankfurt\, ProcureCon Pharma is the only Conference for CPOs & Senior Procurement Executives from leading pharma Companies \n \nJoin 150+ senior procurement professionals from Merck\, AstraZeneca\, Roche\, Sanofi\, Lonza and other world leading Pharma businesses over 2 days and 40 interactive sessions that will help you make better outsourcing decisions\, speed up transformation and co-create value with business partners. To learn more about ProcureCon Pharma\, download the agenda. \nTake away solutions to all of your top challenges: \n\nMaster analytical and digital procurement in pharma\nBuild strategic partnerships with your internal stakeholders\nDesign and train a high-performing global pharma procurement team\nMove beyond savings with key CROS and CMOS to unlock hidden innovation\n\nFor more information including the incredible speaker line-up\, take a look at the conference brochure here: https://bit.ly/2yIP6a1 \nBook your place online today: https://bit.ly/2PvKzS8 and get 15% off the current ticket price with our exclusive discount code – “PCPPJ15”
URL:https://www.pharmajournalist.com/event/procurecon-pharma-2019/
LOCATION:Steigenberger Frankfurter Hof\, Am Kaiserplatz\, Frankfurt/Main\, 60311\, Germany
ORGANIZER;CN="Worldwide Business Research":MAILTO:Procurecon@wbr.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190318
DTEND;VALUE=DATE:20190320
DTSTAMP:20260515T001923
CREATED:20181029T164425Z
LAST-MODIFIED:20181029T164425Z
UID:18183-1552867200-1553039999@www.pharmajournalist.com
SUMMARY:3rd Annual Drug Discovery Chemistry
DESCRIPTION:SMi’s 3rd Annual Drug Discovery Chemistry  \nDeveloping your R&D pipeline with strategies to deliver small molecules  \nConference: 18 – 19 March 2019\nWorkshop: 20 March 2019\nLocation: Copthorne Tara Hotel\, London\, UK\nWebsite: www.drug-discovery.co.uk/PJwl \nCHAIRED BY: \nRoderick Hubbard\, Senior Fellow\, Vernalis Research Ltd\nDarren Green\, Director of Molecular Design\, GSK \nSMi is proud to present its 3rd Annual Drug Discovery Chemistry event\, taking place on the 18th-19th March 2019. \n \nThe fight to optimise the drug discovery process is on as there is currently a reduced output of new medicines within the market\, however\, demand for novel drugs is still steadily increasing.M \nThis year’s event will specifically focus on innovations within the field that has the potential to drive the pharmaceutical industry into a new era of medicines\, with optimization of the R&D process to become cheaper\, faster and increasing the likelihood of drug efficacy and success. These are some of the major obstacles within drug discovery at present\, as the process is overall long\, expensive and often potential drugs will fail late in clinical trials\, wasting resources and time. \nThe event will also focus on novel techniques that can be implemented within the field today that can identify new druggable targets and possibly open new therapeutic areas within the clinic. This could offer opportunities for pharmaceutical companies to produce medicines for diseases and ailments that have previously not been targeted\, and likewise\, offer new drug targets for existing diseases that could potentially offer better clinical outcomes\, such as within the development of cancer drugs. \nDrug Discovery Chemistry 2019 will look at various developments within the field\, guiding companies on how they can best utilize the newest technologies and drug discovery modalities to develop new medicines\, reduce their R&D cost and timelines\, and ultimately\, increase their medicine output for commercial success. \nEvent Hashtag: #SMiDrugDisChem \nKEY SPEAKERS INCLUDE: \n\nVivek Vishnudas\, Senior Vice President Drug discovery & Platform Sciences\, Berg LLC\nTobias Gabriel\, Global Head of Discovery Chemistry\, Novartis\nGovinda Bhisetti\, Principal Investigator and Head of Computational Chemistry\, Biogen\nHasane Ratni\, Expert Scientist\, F Hoffmann-La Roche\nAlexander Hillisch\, Director of Medicinal Chemistry\, Bayer \n\nKEY TOPICS FOR 2018 INCLUDE: \n\nDiscuss the impact of the use of novel computational techniques on R&D pipelines\nHear about the progress in the development of new drugs on difficult targets and how these can revolutionise patient treatment\nDiscover how AI is being utilised in the commercial setting and opportunities to best exploit these to streamline the Drug Discovery Process\nExplore the potential of new modalities to transform therapeutics\nLearn about current strategies to increase drug discovery success \n\nPost conference workshop on 20 March 2019 \nArtificial Intelligence in Drug Discovery \nLed by: Nick Camp\, Consultant \nWHO SHOULD ATTEND \nCEOs\, Presidents\, Vice Presidents and Global Heads\, Executive Directors\, Vice President & Global head\, Principal Scientists\, Heads of Business Development\, Directors of Pharma/Biotech firms. \nEARLY BIRD-RATES \n\nBOOK BY 30 NOVEMBER AND SAVE £400\nBOOK BY 15 DECEMBER AND SAVE £200\nBOOK BY 31 JANUARY AND SAVE £100
URL:https://www.pharmajournalist.com/event/3rd-annual-drug-discovery-chemistry/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Ltd.":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190318
DTEND;VALUE=DATE:20190320
DTSTAMP:20260515T001923
CREATED:20181022T121303Z
LAST-MODIFIED:20181022T121355Z
UID:18094-1552867200-1553039999@www.pharmajournalist.com
SUMMARY:21st Annual Superbugs & Superdrugs Conference
DESCRIPTION:As the global threat of antimicrobial resistance continues to grow\, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections. \n \nSMi’s highly anticipated Superbugs & Superdrugs conference is set to return to London\, UK for its 21st year running\, on the 18th & 19th March 2019. This year’s event aims to provide valuable insights and key updates on the latest developments within the scientific communities\, as well as the processes and strategies pharmaceuticals use to develop novel therapeutics that utilise alternative mechanisms to treat multi-drug resistant infections. \nThe two-day conference will also host a diverse gathering of policy makers and economists\, in addition to big pharmas and biotechs\, who will discuss incentives\, partnerships\, regulations and new policies. Industry experts and scientific pioneers are set to present on their research advances and clinical data\, as well as alternatives to antibiotics\, such as monoclonal antibodies and antimicrobial peptides.  \n2019 HIGHLIGHTS:  \n\nAnalyse the current status of antimicrobial resistance with industry-led insight into current strategies to tackle AMR\nHear about novel immune-therapeutics to target Gram-negative bacterial infections\nLearn about strategies to combat β-lactamases\nEvaluate the development of precision antibiotics: Agents designed to meet the demands of stewardship\nExplore the role of plasmids in the evolution of antimicrobial resistance\n\nJoin us in London next year to explore the challenges and solutions to the growing threat of antibiotic resistance\, as well as take part in interactive roundtable discussions with leading organisations. Attendees will also have the exclusive opportunity of networking with an unrivalled gathering of senior experts from Chemical Biology Ventures\, University of Oxford\, MedImmune\, HPRA\, GARDP\, DNDi\, Bioharmony Therapeutics\, and many more.  \nEarly Bird Discounts!  \nBook by November 30th and save £400\nBook by December 14th and save £200\nBook by January 31st and save £100  \nFor more information and to register online\, please visit http://www.superbugssuperdrugs.com/pjwl
URL:https://www.pharmajournalist.com/event/21st-annual-superbugs-superdrugs-conference/
LOCATION:HOLIDAY INN KENSINGTON FORUM\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:mmandic@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190314
DTEND;VALUE=DATE:20190315
DTSTAMP:20260515T001923
CREATED:20190121T082920Z
LAST-MODIFIED:20190208T080646Z
UID:19169-1552521600-1552607999@www.pharmajournalist.com
SUMMARY:2nd Annual Pharma Regulatory Summit 2019
DESCRIPTION:Pharma Regulatory Summit is the leading platform for regulatory experts\, to be updated with latest country updates and strategies to navigate the complex and ever changing regulations in the region. This conference will focus on the new strategies\, amendments\, innovations\, developments in the fields of regulatory affairs\, intellectual property and medical devices\, which reflects new strategies in the field of regulatory affairs. \nSPONSORS: \n\nExhibitor: Nishith Desai Associates\n\nCONFERENCE REGISTRATION PROCESS: \nE-mail – kavitha@virtueinsight.co.in  Tel: +9144 24762472 \n\nEarly Bird Discount Price (Ends 28th January 2019) – (INR 10\,000 + GST (18%) per delegate)\nStandard Price (From 29th January 2019 Onwards) – (INR 15\,000 + GST (18%) per delegate)\nSponsor\, Exhibition Stall (Booth) and a paid Speaker Slots are also available\n\nGet more from the event\, with a broader scope bringing the whole communications value chain together.
URL:https://www.pharmajournalist.com/event/2nd-annual-pharma-regulatory-summit-2019/
LOCATION:Kohinoor Continental Hotel\, Mumbai\, India\, Mumbai\, India
ORGANIZER;CN="Virtue Insight":MAILTO:kavitha@virtueinsight.co.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190313
DTEND;VALUE=DATE:20190315
DTSTAMP:20260515T001923
CREATED:20181128T145711Z
LAST-MODIFIED:20181128T145711Z
UID:18580-1552435200-1552607999@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply Europe 2019
DESCRIPTION:This year’s Clinical Trial Supply Europe celebrates its 20th year! As a result of this special occasion we have worked hard to prepare a leading industry agenda which makes this event a must attend in the industries calendar. We have built on last year’s incredibly successful conference and are returning with full force to Milan with the aim of supporting trial sponsors and solution providers across Europe to ensure trials are delivered on time\, partnerships are improved and supply chain uncertainties are resolved. \n \nWe will once again be meeting in Milan\, Italy\, to discuss\, deliberate and debate the latest operational and technological challenges with regards to clinical trial supplies. Over the course of two days you can expect to catch-up with old colleagues and make new lasting business connections to help drive success in your trials. As Arena’s largest CTS conference this event promises to be a must attend for the industry! \nAt each Clinical Trial Supply conference we create a welcoming networking environment and an educational program packed with the latest case studies\, techniques and providers to set your trial apart. This year is no different as we have a vast array of fascinating case-studies\, thought leading presentations and engaging panels. \nThis year we will be looking at issues such as\, but not limited to discovering the practical benefits of e-labelling; how this technological innovation can expedite packaging and labelling timelines\, ways to move beyond the theory; harnessing the power of technology to design a functioning Direct to Patient (DtP) supply chain and whether blockchain’s time come? Is blockchain a buzzword or an actionable tool for disrupting operations? \nWith such a packed program you can’t afford to miss out. We look forward to meeting you in Milan so make sure to book your place today!
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-europe-2019/
LOCATION:Milan\, Italy
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190313
DTEND;VALUE=DATE:20190315
DTSTAMP:20260515T001923
CREATED:20181128T145347Z
LAST-MODIFIED:20181128T145347Z
UID:18574-1552435200-1552607999@www.pharmajournalist.com
SUMMARY:Temperature Controlled Logistics in Biopharmaceuticals Europe 2019
DESCRIPTION:Facilitating a platform for the pharmaceutical industry to refine their temperature controlled logistics strategy to ensure an overall successful supply chain \n \nThe 15th Annual Temperature Controlled Logistics in Biopharmaceuticals returns to Milan\, after an extremely successful 2018 event. The largest European clinical and commercial pharmaceutical supply chain will bring together industry experts to examine the ever changing market and how these new dynamics will impact how the sector operates. \nOur 2019 agenda will focus on providing a holistic approach to the pharmaceutical supply chain to ensure the quality\, efficacy and safety of your product during temperature controlled shipments. \nAvoiding death by power point our 2 day event will facilitate interactive and engaging sessions from panel discussions\, roundtables\, fireside chats and case studies to give rise to innovation solutions to existing challenges. \nKey topics for 2019 will include: \n\nDeveloping risk mitigation management plans\nRefining your shipping lines to reduce temperature deviations\nAdding metrics whilst comparing air\, rail and sea distribution to determine the best transportation method for each product\nSeparating the hype to give rise to practical tangible solutions of how to incorporate blockchain into your supply chain\n\nJoin us in March to be a part of the discussions to refine your temperature controlled logistics strategy. Click here to book your place now
URL:https://www.pharmajournalist.com/event/temperature-controlled-logistics-in-biopharmaceuticals-europe-2019/
LOCATION:Milan\, Italy
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190312
DTEND;VALUE=DATE:20190314
DTSTAMP:20260515T001923
CREATED:20190215T073218Z
LAST-MODIFIED:20190215T073413Z
UID:19570-1552348800-1552521599@www.pharmajournalist.com
SUMMARY:Outsourcing Clinical Trials Israel 2019
DESCRIPTION:Arena International is thrilled to announce that the fifth Outsourcing in Clinical Trials conference is returning to Tel Aviv\, 12th – 13th March\, 2019\, the only clinical outsourcing platform for biotech\, pharmaceutical and medical device companies within Israel. \nAs with its reputation\, this conference addresses how companies can effectively develop their outsourcing strategies and attendees with attain an increased understanding of how to enhance their operational efficiencies to ensure timely and cost-effective clinical studies. \nThis conference is equally an exclusive place in which delegate will network with industry professionals and service providers\, as well as attending insightful lectures from senior representatives from entrepreneurial companies within the Israeli Life Sciences sector. \nWe invite you to join us in March 2019\, register your place today.
URL:https://www.pharmajournalist.com/event/outsourcing-clinical-trials-israel-2019/
LOCATION:We are pleased to announce the venue is now confirmed. To request the venue details please contact us at events@arena-international.com
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190312
DTEND;VALUE=DATE:20190315
DTSTAMP:20260515T001923
CREATED:20181206T112043Z
LAST-MODIFIED:20181206T112357Z
UID:18687-1552348800-1552607999@www.pharmajournalist.com
SUMMARY:CPhI South East Asia 2019
DESCRIPTION:CPhI South East Asia will move to Bangkok\, Thailand in March 12-14 for the first time. Featuring the co-located with FDF\, ICSE\, P-MEC\, InnoPack\, and LABworld South East Asia\, CPhI South East Asia 2019 will host more than 6\,000 attendees and 270 exhibitors. CPhI South East Asia offers you the chance to do business in a booming and expanding market\, meet the movers and shakers of the South East Asian pharma industry and keep up to date with trending news and topics. \nWhether you are looking for sourcing new business or getting the latest market insight\, this is your ONE-STOP – SHOP pharmaceutical platform in South East Asia. \nTo learn more about this event\, visit www.cphi.com/sea
URL:https://www.pharmajournalist.com/event/cphi-south-east-asia-2019/
LOCATION:Queen Sirikit National Convention Center (QSNCC)\, 60 New Rachadapisek Road\, Klongtoey\, Bangkok\, 10110\, Thailand
ORGANIZER;CN="UBM Asia (Thailand)":MAILTO:Nureen.c@ubm.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190226
DTEND;VALUE=DATE:20190301
DTSTAMP:20260515T001923
CREATED:20190213T093921Z
LAST-MODIFIED:20190214T153157Z
UID:19523-1551139200-1551398399@www.pharmajournalist.com
SUMMARY:AsiaTIDES: Oligonucleotide & Peptide Therapeutics
DESCRIPTION:AsiaTIDES is the only event in Asia that brings together the science\, technologies and partners you need to accelerate your oligonucleotide and peptide molecules to market. Join 300+ scientists and executives at this upcoming meeting featuring keynote speakers from Novo Nordisk A/S\, Ionis Pharmaceuticals\, Alnylam Pharmaceuticals\, and WAVE Life Sciences. \n \nRegister now at www.AsiaTIDESEvent.com with code “PHARMJ10” and SAVE 10%.
URL:https://www.pharmajournalist.com/event/asiatides-oligonucleotide-peptide-therapeutics/
LOCATION:Hilton Tokyo Bay Hotel | Tokyo\, Japan
ORGANIZER;CN="Knect365 Life Sciences":MAILTO:Allison.macdonald@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190225
DTEND;VALUE=DATE:20190227
DTSTAMP:20260515T001923
CREATED:20190108T100940Z
LAST-MODIFIED:20190108T100940Z
UID:18951-1551052800-1551225599@www.pharmajournalist.com
SUMMARY:Global NASH Congress
DESCRIPTION:Attracting experts working in all areas of nonalcoholic steatohepatitis\, the Global NASH Congress will examine the latest research and development in pathogenesis\, diagnosis\, and treatment of the disease. An increasing number of people are being diagnosed with the nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) each year\, and the primary method of treatment is weight loss. With no approved medicines on the market\, the drug development race is intensifying. The pathogenesis of NASH is still not fully understood\, and definitive diagnostic methods are invasive\, so development has been slow. There are\, however\, promising developments in research that will hopefully bolster drug development and other methods of treatment. Examples of such developments include improved in vivo liver models\, non-invasive diagnostic biomarkers and a better understanding of the disease’s mechanisms. This year’s congress will focus on these exciting advancements\, as well as on the challenges of preclinical and clinical research in NASH. There will also be a session on business development/regulation and a showcase of the most promising therapeutics in development.
URL:https://www.pharmajournalist.com/event/global-nash-congress/
LOCATION:London\, United Kingdom\, London Heathrow Marriott Hotel\, London\, United Kingdom
ORGANIZER;CN="Global Engage":MAILTO:kieran@globalengage.co.uk
END:VEVENT
END:VCALENDAR